Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcumin + hyaluronic acid is a conjugate formulation that combines the therapeutic properties of curcumin with the targeting capabilities of hyaluronic acid. This combination creates a self-assembling nanoparticle system that can enhance curcumin's solubility, stability, and bioavailability. The hyaluronic acid component enables CD44 receptor-mediated targeted delivery to cells expressing CD44, which is found on various cancer cells. This conjugate has shown efficacy in preventing urinary tract infections and reversing multidrug resistance in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcumin + hyaluronic acid.